Hydrazine hydrate (1:1) → HCID 59716704, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[N:12][N:11]3[C:14](=[O:30])[N:15]([CH2:17][CH2:18][N:19]4C(=O)C5C(=CC=CC=5)C4=O)[N:16]=[C:10]3[C:9]=2[C:31]2[CH:36]=[CH:35][C:34]([Cl:37])=[CH:33][CH:32]=2)=[CH:4][CH:3]=1.O.NN>C(O)C.C(OCC)(=O)C>[NH2:19][CH2:18][CH2:17][N:15]1[C:14](=[O:30])[N:11]2[N:12]=[CH:13][C:8]([C:5]3[CH:6]=[CH:7][C:2]([Cl:1])=[CH:3][CH:4]=3)=[C:9]([C:31]3[CH:32]=[CH:33][C:34]([Cl:37])=[CH:35][CH:36]=3)[C:10]2=[N:16]1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
2-(2-(7,8-Bis(4-chlorophenyl)-3-oxo-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)ethyl)isoindoline-1,3-dione (180 mg, 0.34 mmol) was reacted with hyrazine hydrate (0.9 ml, 18.5 mmol) in ethanol (10 ml) and stirred overnight. After this time, the reaction mixture was diluted with ethyl acetate and washed with saturated aqueous NaCl. The organic layer was dried over Na2SO4, filtered and concentrated. The crude material was purified by preparative HPLC to give the title compound, 2-(2-aminoethyl)-7,8-bis(4-chlorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one (22 mg, 13%) as a yellow foam. MS M+H=400; 1H NMR (CDCl3) δ 8.12 (broad, 2H), 7.38-7.15 (6H), 7.05 (2H), 4.45 (2H), 3.59 (2H).
Workup
- washwashed with saturated aqueous NaCl
- dry with materialThe organic layer was dried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customThe crude material was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-3d11b875d17f47a58642ccc6a7e6f2b8
- Source dataset
- uspto-grants-2008_05
- Patent number
- US07378418B2
Reaction notes
Loading…